21 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
16
Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors.
The Scripps Research Institute
5
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
University of Minnesota
15
An update on therapeutic opportunities offered by cancer glycolytic metabolism.
University of Pisa
30
Monocarboxylate transporter 1 inhibitors as potential anticancer agents.
Medical School Duluth
8
Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors.
The Scripps Research Institute
9
Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
Physiologisch-Chemisches Institut Der Eberhard-Karls-Universit£T T£Bingen
10
Functional and structural polypharmacology of indazole-based privileged ligands to tackle the undruggability of membrane transporters.
University of Lubeck and University Medical Center Schleswig-Holstein
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
University of Cambridge
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
108
pH regulators and their inhibitors in tumor microenvironment.
University of South China
19
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1).
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management
17
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology.
AstraZeneca
21
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management
8
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.
Guang Xi University of Chinese Medicine
59
Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using Same
Baylor College of Medicine
9
Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity
University of Carthage